Literature DB >> 26324125

miR-1291 targets mucin 1 inhibiting cell proliferation and invasion to promote cell apoptosis in esophageal squamous cell carcinoma.

Hailan Luo1, Wentao Guo1, Fei Wang1, Yanjie You1, Jianguo Wang1, Xudong Chen1, Jihong Wang1, Yuanyuan Wang2, Yuwen Du2, Xiaonan Chen2, Changgui Xue2, Guohua Song1, Fuqing Wang1.   

Abstract

MicroRNAs (miRNAs) are well known as important regulators in various cancer development. In the present study, we focused on the expression and biological function of miR-1291 in esophageal squamous cell carcinoma (ESCC). Compared with adjacent non-tumorous tissue samples, qRT-PCR data showed significant downregulation of miR-1291 in 54 ESCC tissue samples (P<0.05), which was also significantly associated with lymph node metastases and clinical stage (P<0.05). Cell Counting Kit-8 (CCK-8), colony formation, Transwell and flow cytometric apoptosis assays were performed to detect the effect of miR-1291 upregulation, and the results showed inhibition of the proliferation, invasion and promotion of apoptosis in EC9706 and EC-1 cells. Using bioinformatic analyses, we found that mucin 1 (MUC1) was a potential target for miR-1291. Luciferase assays were performed to reveal that miR-1291 inhibited MUC1 expression by targeting the seed region of MUC1 3'-untranslated region (3'UTR). We also found that the expression of MUC1 lacking in 3'UTR abrogated the anti-invasion and pro-apoptosis function of miR-1291. Our results demonstrated the importance of miR-1291 in targeting MUC1 for the regulation of esophagus cancer growth, invasion and apoptosis, and may be helpful for developing new targets for early diagnosis or new therapeutic targets for ESCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26324125     DOI: 10.3892/or.2015.4206

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

1.  Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.

Authors:  Neven A Hagag; Yasser B M Ali; Ahmed A Elsharawy; Roba M Talaat
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.

Authors:  Mei-Juan Tu; Pui Yan Ho; Qian-Yu Zhang; Chao Jian; Jing-Xin Qiu; Edward J Kim; Richard J Bold; Frank J Gonzalez; Huichang Bi; Ai-Ming Yu
Journal:  Cancer Lett       Date:  2018-10-30       Impact factor: 8.679

3.  Long non-coding RNA TRPM2 antisense RNA as a potential therapeutic target promotes tumorigenesis and metastasis in esophageal cancer.

Authors:  Wei Wang; Yukai Dai; Xin Yang; Xinming Xiong
Journal:  Bioengineered       Date:  2022-02       Impact factor: 6.832

4.  miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2.

Authors:  Ling Ye; Tao Jiang; Huanzhang Shao; Lin Zhong; Zhaowen Wang; Yuan Liu; Huamei Tang; Bingyu Qin; Xiaoqing Zhang; Junwei Fan
Journal:  Mol Ther Nucleic Acids       Date:  2017-05-12

5.  Chronic low-dose exposure to a mixture of environmental endocrine disruptors induces microRNAs/isomiRs deregulation in mouse concomitant with intratesticular estradiol reduction.

Authors:  Julio Buñay; Eduardo Larriba; Ricardo D Moreno; Jesús Del Mazo
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

6.  Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13.

Authors:  Liang He; Linlin Qu; Lijing Wei; Yan Chen; Jian Suo
Journal:  Mol Med Rep       Date:  2017-03-22       Impact factor: 2.952

7.  MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis.

Authors:  Mei-Juan Tu; Yu-Zhuo Pan; Jing-Xin Qiu; Edward J Kim; Ai-Ming Yu
Journal:  Oncotarget       Date:  2016-07-19

8.  A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.

Authors:  Yixin Chen; Yanying Zhou; Fangwei Han; Yingyuan Zhao; Meijuan Tu; Yongtao Wang; Can Huang; Shicheng Fan; Panpan Chen; Xinpeng Yao; Lihuan Guan; Ai-Ming Yu; Frank J Gonzalez; Min Huang; Huichang Bi
Journal:  Theranostics       Date:  2020-06-01       Impact factor: 11.556

Review 9.  C1GALT1 in health and disease.

Authors:  Xiaojie Sun; Mengru Zhan; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Oncol Lett       Date:  2021-06-06       Impact factor: 2.967

10.  Aberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis.

Authors:  Shipeng Zhao; Qiang Chen; Xianwu Kang; Bin Kong; Zhuo Wang
Journal:  Biomed Res Int       Date:  2018-08-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.